Back to TARS
Assenagon Asset Management S.A. → TARS
Assenagon Asset Management S.A. TARS Position History
Tarsus Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$48.4M
Q3 2026
Peak value
$92.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $74.2M |
| Q4 2025 | $92.3M |
| Q1 2026 | $89.8M |
| Q2 2026 | $59.6M |
| Q2 2026 | $59.6M |
| Q3 2026 | $48.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $48.4M | 616.0K | — | — |
| Q2 2026 | $59.6M | 947.5K | — | — |
| Q2 2026 | $59.6M | 947.5K | — | — |
| Q1 2026 | $89.8M | 1.28M | — | — |
| Q4 2025 | $92.3M | 1.13M | — | — |
| Q3 2025 | $74.2M | 1.25M | — | — |
Other funds holding TARS
$155.5M
$126.3M
$105.9M
$101.3M
$68.6M
$67.5M
$67.5M